Aug 23, 2017
CRISPR has been in the limelight for a very long time, and now it has again touched headlines, not for another milestone, but for a reason that might question the positive effects, it boasts of creating in the research sphere. Two independent researchers at Rockefeller University and New York University edited orco ...
Read More...
Discover How Learning Disability Treatment Landscape is Evolving with the Emergence of Digital Assistant Technologies
Jul 04, 2025
A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray
Jun 10, 2025
LEQEMBI: A New Hope for Alzheimer’s Disease Patients
Feb 12, 2025
-Agonist.png "Toll-like Receptors Agonist")
Newsletter/Whitepaper